Difference between revisions of "Team:Manchester-Graz/Attributions"
Martin2801 (Talk | contribs) |
Martin2801 (Talk | contribs) |
||
Line 32: | Line 32: | ||
− | |||
<h2>Manchester Institute of Biotechnology</h2> | <h2>Manchester Institute of Biotechnology</h2> | ||
Line 48: | Line 47: | ||
<li>Prof. Dr. Christoph Sensen: general support regarding organizational work and social media</li> | <li>Prof. Dr. Christoph Sensen: general support regarding organizational work and social media</li> | ||
<li>Dr. Martina Geier: supported us during the whole iGEM process not only with the organization of our team but also during our lab work</li> | <li>Dr. Martina Geier: supported us during the whole iGEM process not only with the organization of our team but also during our lab work</li> | ||
− | <li> | + | <li>Christian Schmid: helped us with organization and shipment of products from our sponsors</li> |
− | <li>Dr. Birgit | + | <li>Dr. Birgit Wiltschi: helped us with our Vector Design and gave general support during the vector assembly process</li> |
<li>Prof Dr. Eriko Takano: UoM iGEM organizer, Supervisor and primary team contact, supervision</li> | <li>Prof Dr. Eriko Takano: UoM iGEM organizer, Supervisor and primary team contact, supervision</li> | ||
<li>Prof Dr. Reiner Breitling: modeling advisor, supervision</li> | <li>Prof Dr. Reiner Breitling: modeling advisor, supervision</li> | ||
− | <li>Prof Dr. Sabine | + | <li>Prof Dr. Sabine Flitsch: supervision, inter-European team idea organizer, gut bacteria idea, PD patient interview organizer </li> |
<li>Lorna Hepworth: supervision, new techniques explanation </li> | <li>Lorna Hepworth: supervision, new techniques explanation </li> | ||
<li>Alexander Wood: supervision, lab help, HPLC expert</li> | <li>Alexander Wood: supervision, lab help, HPLC expert</li> | ||
Line 65: | Line 64: | ||
<ul> | <ul> | ||
<li>Prof. Dr. Reidl: Discussion about human gut bacteria composition, feasibility of our project idea, general background knowledge exchange, ethic background</li> | <li>Prof. Dr. Reidl: Discussion about human gut bacteria composition, feasibility of our project idea, general background knowledge exchange, ethic background</li> | ||
− | <li>Dr. | + | <li>Dr. Christoph Högenauer: Discussion about treatment of Parkinson patients, feasibility and possible application of the DopaDoser |
Modeling Support</li> | Modeling Support</li> | ||
<li>Dr. Monty Silverdale: interview form a practicing doctor and opinions on our project</li> | <li>Dr. Monty Silverdale: interview form a practicing doctor and opinions on our project</li> |
Revision as of 10:01, 3 September 2015
Attributions
Manchester Institute of Biotechnology
- Dr. Peter Both
- Adrian Jarvis
- Sandra Taylor
- Rehana
- Dr Neil Swainston
General Support
- Prof. Dr. Anton Glieder: Supervision of Team Graz, organizational work
- Prof. Dr. Christoph Sensen: general support regarding organizational work and social media
- Dr. Martina Geier: supported us during the whole iGEM process not only with the organization of our team but also during our lab work
- Christian Schmid: helped us with organization and shipment of products from our sponsors
- Dr. Birgit Wiltschi: helped us with our Vector Design and gave general support during the vector assembly process
- Prof Dr. Eriko Takano: UoM iGEM organizer, Supervisor and primary team contact, supervision
- Prof Dr. Reiner Breitling: modeling advisor, supervision
- Prof Dr. Sabine Flitsch: supervision, inter-European team idea organizer, gut bacteria idea, PD patient interview organizer
- Lorna Hepworth: supervision, new techniques explanation
- Alexander Wood: supervision, lab help, HPLC expert
- Nicholas Weise: supervision, lab help , HPLC expert
- Robert Harrison: supervision, HP explanation, help in contacting
Human Practices
- Prof. Dr. Reidl: Discussion about human gut bacteria composition, feasibility of our project idea, general background knowledge exchange, ethic background
- Dr. Christoph Högenauer: Discussion about treatment of Parkinson patients, feasibility and possible application of the DopaDoser Modeling Support
- Dr. Monty Silverdale: interview form a practicing doctor and opinions on our project
- Prof Dr. Angela Tod: interview
- Julia: PD patient interview with shedding light on PD and our project from a patient’s point of view
- Dr Andy Balmer: HP explanation
Modeling
- Areti Tsigkinopoulou: Supported the model developing process of a quorum sensing system, general Matlab and Simbiology support
- Dr Neil Swainston: introducing MatLab, explaining Flux Balance Analysis modeling and guiding us throughout the project on modeling